Evidence map›Paper›PMID 36676055›Full record

ArticleLife (Basel, Switzerland)2022

Lack of Skeletal Effects in Mice with Targeted Disruptionof Prolyl Hydroxylase Domain 1 (

Weirong Xing, Destiney Larkin, Sheila Pourteymoor, William Tambunan, Gustavo A Gomez, Elaine K Liu, Subburaman Mohan

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Weirong XingMusculoskeletal Disease Center, Loma Linda VA Healthcare System, Loma Linda, CA 92357, USA.
Destiney LarkinMusculoskeletal Disease Center, Loma Linda VA Healthcare System, Loma Linda, CA 92357, USA.
Sheila PourteymoorMusculoskeletal Disease Center, Loma Linda VA Healthcare System, Loma Linda, CA 92357, USA.
William TambunanMusculoskeletal Disease Center, Loma Linda VA Healthcare System, Loma Linda, CA 92357, USA.
Gustavo A GomezMusculoskeletal Disease Center, Loma Linda VA Healthcare System, Loma Linda, CA 92357, USA.
Elaine K LiuMusculoskeletal Disease Center, Loma Linda VA Healthcare System, Loma Linda, CA 92357, USA.
Subburaman MohanMusculoskeletal Disease Center, Loma Linda VA Healthcare System, Loma Linda, CA 92357, USA.ORCID 0000-0003-0063-986X
VA Loma Linda Healthcare System · USLoma Linda University · US

Funding

BLRD VA I01 BX001396BLRD VA IK6 BX005381
6 · The paper itself

Abstract

The critical importance of hypoxia-inducible factor (HIF)s in the regulation of endochondral bone formation is now well established. HIF protein levels are closely regulated by the prolyl hydroxylase domain-containing protein (PHD) mediated ubiquitin-proteasomal degradation pathway. Of the three PHD family members expressed in bone, we previously showed that mice with conditional disruption of the Phd2 gene in chondrocytes led to a massive increase in the trabecular bone mass of the long bones. By contrast, loss of Phd3 expression in chondrocytes had no skeletal effects. To investigate the role of Phd1 expressed in chondrocytes on skeletal development, we conditionally disrupted the Phd1 gene in chondrocytes by crossing Phd1 floxed mice with Collagen 2α1-Cre mice for evaluation of a skeletal phenotype. At 12 weeks of age, neither body weight nor body length was significantly different in the Cre+; Phd1flox/flox conditional knockout (cKO) mice compared to Cre−; Phd1flox/flox wild-type (WT) control mice. Micro-CT measurements revealed significant gender differences in the trabecular bone volume adjusted for tissue volume at the secondary spongiosa of the femur and the tibia for both genotypes, but no genotype differences were found for any of the trabecular bone measurements of either femur or tibia. Similarly, cortical bone parameters were not affected in the Phd1 cKO mice compared to control mice. Histomorphometric analyses revealed no significant differences in bone area, bone formation rate or mineral apposition rate in the secondary spongiosa of femurs between cKO and WT control mice. Loss of Phd1 expression in chondrocytes did not affect the expression of markers of chondrocytes (collage 2, collagen 10) or osteoblasts (alkaline phosphatase, bone sialoprotein) in the bones of cKO mice. Based on these and our published data, we conclude that of the three PHD family members, only Phd2 expressed in chondrocytes regulates endochondral bone formation and development of peak bone mass in mice.

Indexed as

chondrocyteendochondral bone formationhypoxia-inducible factorknockout miceosteoblastPhd1 genePHD proteinphenotypeprolyl hydroxylase domain-containing protein

Identifiers

PMID36676055
PMCPMC9862499
OpenAlexW4313317174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.